Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting
- PMID: 20002854
- DOI: 10.1111/j.1445-5994.2009.02136.x
Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting
Abstract
Background: Osteoarticular infections are a primary indication for outpatient parenteral antimicrobial therapy (OPAT). The climate and geographical diversity of tropical Australia, together with the prevalence of melioidosis, disseminated gonococcal disease and community-acquired methicillin-resistant Staphylococcus aureus renders this a challenging environment in which to manage such infections. We evaluated patients managed by the Royal Darwin Hospital Hospital in the Home service for bone and joint infections.
Methods: A retrospective analysis of the therapeutic outcomes at the end of intravenous therapy was carried out for patients treated between 1 January 2006 and 15 September 2007.
Results: Fifty-five patients were treated, including 21 (38%) indigenous Australians and 18 (33%) from remote communities. Baseline characteristics were similar to other published data, but there were two cases each of gonococcal septic arthritis and melioidosis. During treatment, 39 (71%) lived at home, with five (9%) of these receiving treatment at community clinics. Thirteen (24%) resided in self-care units in the hospital grounds. Three (5%) were managed at hostels or in prison. Median duration of parenteral therapy was 42 days, with a median of 22 days outside hospital, providing a total saving of 1307 bed-days. Clinical success at end of therapy was 84%, with no significant difference between indigenous and non-indigenous cohorts.
Conclusion: OPAT for osteoarticular infections is both feasible and effective in a tropical environment, including for indigenous patients. Extension of treatment to remote-dwelling patients is facilitated by the innovative use of self-care units and administration of treatment at remote clinics.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.
Similar articles
-
[Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].Med Mal Infect. 2006 Mar;36(3):132-7. doi: 10.1016/j.medmal.2006.01.002. Epub 2006 Mar 31. Med Mal Infect. 2006. PMID: 16580802 Review. French.
-
Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital.N Z Med J. 2004 Aug 20;117(1200):U1020. N Z Med J. 2004. PMID: 15475990
-
Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.Int J Antimicrob Agents. 2012 May;39(5):407-13. doi: 10.1016/j.ijantimicag.2012.01.016. Epub 2012 Mar 23. Int J Antimicrob Agents. 2012. PMID: 22445493
-
Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters.Trop Med Int Health. 2004 Jun;9(6):715-7. doi: 10.1111/j.1365-3156.2004.01244.x. Trop Med Int Health. 2004. PMID: 15189462
-
[Teicoplanin in the treatment of bone and joint infections due to methicillin resistant staphylococci. Experience in adult patients].Medicina (B Aires). 2002;62 Suppl 2:40-7. Medicina (B Aires). 2002. PMID: 12481488 Review. Spanish.
Cited by
-
Outpatient Parenteral Antimicrobial Therapy Practice in United Kingdom: A Single-center Experience.Oman Med J. 2022 Nov 30;37(6):e442. doi: 10.5001/omj.2023.26. eCollection 2022 Nov. Oman Med J. 2022. PMID: 36458250 Free PMC article.
-
A Retrospective Case-Series of Children With Bone and Joint Infection From Northern Australia.Medicine (Baltimore). 2016 Feb;95(8):e2885. doi: 10.1097/MD.0000000000002885. Medicine (Baltimore). 2016. PMID: 26937926 Free PMC article.
-
Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years.Infection. 2018 Jun;46(3):349-355. doi: 10.1007/s15010-018-1126-4. Epub 2018 Feb 20. Infection. 2018. PMID: 29464675
-
Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.BMJ Open. 2017 Apr 20;7(4):e013560. doi: 10.1136/bmjopen-2016-013560. BMJ Open. 2017. PMID: 28428184 Free PMC article.
-
Burkholderia Pseudomallei Causing Bone and Joint Infections: A Clinical Update.Infect Dis Ther. 2016 Mar;5(1):17-29. doi: 10.1007/s40121-015-0098-2. Epub 2016 Jan 4. Infect Dis Ther. 2016. PMID: 26728713 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical